Drugs / HIV p24/MF59 Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00002204 | — | HIV infectious disease, seronegative autoimmune hepatitis | Chiron Corporation | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HIV p24/MF59 Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00002204 ↗ |
| Modality | Vaccine | “Chiron vaccine human immunodeficiency virus (HIV) p24(25 or 50 micrograms)/MF59” NCT00002204 ↗ |